Justice Must Satisfy the Appearance of Justice a Judge S Family S Financial Interest of 100 Shares of a Party S Stock Is a Serious Issue
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
CENTRIPETAL NETWORKS, INC. v. CISCO SYSTEMS, INC.
Before Dyk, Taranto, and Cunningham. Appeal from the United States District Court for the Eastern District of Virginia.
Summary: Placing stock in a blind trust does not divest a judge of that stock for purposes of the judicial ethics statutes.
After a 22-day bench trial in a patent case between Centripetal Networks and Cisco, Judge Morgan learned that his wife owned 100 shares of Cisco stock valued at $4,687.99. Instead of selling the stock, Judge Morgan placed the stock in a blind trust. Judge Morgan then denied Cisco’s motion requesting Judge Morgan’s recusal under 28 U.S.C. § 455, reasoning that placing the stock in a blind trust “cured” any conflict and that selling the stock would “imply[] concern about insider trading.” Judge Morgan ultimately held that Cisco willfully infringed Centripetal’s patents and awarded enhanced damages and royalties exceeding $2.75 billion.
On appeal, the Federal Circuit reversed. The Federal Circuit concluded that placing the stock in a blind trust did not “divest” Judge Morgan of the stock under the judicial ethics statutes because “ownership” can only be “divested” if the interest is sold or given away. The Court also noted that selling the stock would not have suggested the appearance of insider trading because “comply[ing] with ethical obligations is not insider trading.” Stressing the importance of judiciary credibility and the public’s confidence in the judicial process, the Federal Circuit also held that the appropriate remedy is to vacate the rulings which were issued after Judge Morgan learned of his wife’s financial interest in Cisco. Thus, the Federal Circuit, in part, reversed, vacated, and remanded Judge Morgan’s orders.
Editor: Paul Stewart
Written by: Nima Zargari, Ph.D. & Daniel P. Hughes
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…